Literature DB >> 21130821

Modeling neurodegenerative disease pathophysiology in thiamine deficiency: consequences of impaired oxidative metabolism.

Shivraj S Jhala1, Alan S Hazell.   

Abstract

Emerging evidence suggests that thiamine deficiency (TD), the cause of Wernicke's encephalopathy, produces alterations in brain function and structural damage that closely model a number of maladies in which neurodegeneration is a characteristic feature, including Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, multiple sclerosis, along with alcoholic brain disease, stroke, and traumatic brain injury. Impaired oxidative metabolism in TD due to decreased activity of thiamine-dependent enzymes leads to a multifactorial cascade of events in the brain that include focal decreases in energy status, oxidative stress, lactic acidosis, blood-brain barrier disruption, astrocyte dysfunction, glutamate-mediated excitotoxicity, amyloid deposition, decreased glucose utilization, immediate-early gene induction, and inflammation. This review describes our current understanding of the basis of these abnormal processes in TD, their interrelationships, and why this disorder can be useful for our understanding of how decreased cerebral energy metabolism can give rise to cell death in different neurodegenerative disease states.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21130821     DOI: 10.1016/j.neuint.2010.11.019

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  31 in total

1.  Association Between Reduced Brain Glucose Metabolism and Cortical Thickness in Alcoholics: Evidence of Neurotoxicity.

Authors:  Dardo G Tomasi; Corinde E Wiers; Ehsan Shokri-Kojori; Amna Zehra; Veronica Ramirez; Clara Freeman; Jamie Burns; Christopher Kure Liu; Peter Manza; Sung W Kim; Gene-Jack Wang; Nora D Volkow
Journal:  Int J Neuropsychopharmacol       Date:  2019-09-01       Impact factor: 5.176

Review 2.  Thiamine deficiency: an update of pathophysiologic mechanisms and future therapeutic considerations.

Authors:  Eman Abdou; Alan S Hazell
Journal:  Neurochem Res       Date:  2014-10-09       Impact factor: 3.996

3.  Bioinformatic Analysis of Exosomal MicroRNAs of Cerebrospinal Fluid in Ischemic Stroke Rats After Physical Exercise.

Authors:  Mudan Huang; Chongjun Xiao; Liying Zhang; Lili Li; Jing Luo; Lilin Chen; Xiquan Hu; Haiqing Zheng
Journal:  Neurochem Res       Date:  2021-03-11       Impact factor: 3.996

4.  Long-term treatment with thiamine as possible medical therapy for Friedreich ataxia.

Authors:  Antonio Costantini; Tiziana Laureti; Maria Immacolata Pala; Marco Colangeli; Simona Cavalieri; Elisa Pozzi; Alfredo Brusco; Sandro Salvarani; Carlo Serrati; Roberto Fancellu
Journal:  J Neurol       Date:  2016-08-03       Impact factor: 4.849

5.  Metabolic Dysfunction of Astrocyte: An Initiating Factor in Beta-amyloid Pathology?

Authors:  Liang-Jun Yan; Ming Xiao; Ran Chen; Zhiyou Cai
Journal:  Aging Neurodegener       Date:  2013-08

6.  Thiamine deficiency induces anorexia by inhibiting hypothalamic AMPK.

Authors:  M Liu; A P Alimov; H Wang; J A Frank; W Katz; M Xu; Z-J Ke; J Luo
Journal:  Neuroscience       Date:  2014-03-05       Impact factor: 3.590

Review 7.  Astrocyte and Alzheimer's disease.

Authors:  Zhiyou Cai; Cheng-Qun Wan; Zhou Liu
Journal:  J Neurol       Date:  2017-08-18       Impact factor: 4.849

Review 8.  Epileptic seizures in nonalcoholic Wernicke's encephalopathy: a case report and literature review.

Authors:  Wenjin Shang; Xiuhui Chen; Xunhua Li; Hongbing Chen; Shujin Tang; Hua Hong
Journal:  Metab Brain Dis       Date:  2017-09-06       Impact factor: 3.584

9.  Thiamine Deficiency Induced Dietary Disparity Promotes Oxidative Stress and Neurodegeneration.

Authors:  Anisha Chauhan; Nidhi Srivastva; Parvesh Bubber
Journal:  Indian J Clin Biochem       Date:  2017-09-01

10.  Thiamine and spinocerebellar ataxia type 2.

Authors:  Antonio Costantini; Maria Immacolata Pala; Marco Colangeli; Serena Savelli
Journal:  BMJ Case Rep       Date:  2013-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.